Treating fatigue

Int MS J. 2007 Jun;14(2):64-71.

Abstract

Fatigue is recognized as one of the most disabling and common symptoms of MS. However, no universal consensus has been reached regarding a formal definition for fatigue, and its mechanisms and causes are not understood. This review summarizes important research in this field and recommends a multidisciplinary approach to managing MS patients with fatigue. Such an approach should include proven pharmaceutical and non-pharmaceutical treatments.

Publication types

  • Review

MeSH terms

  • Amantadine / therapeutic use*
  • Central Nervous System Stimulants / therapeutic use*
  • Comorbidity
  • Diagnosis, Differential
  • Dopamine Agents / therapeutic use*
  • Evidence-Based Medicine
  • Fatigue / drug therapy
  • Fatigue / etiology
  • Fatigue / therapy*
  • Humans
  • Multiple Sclerosis / physiopathology*
  • Patient Care Team
  • Pemoline / therapeutic use*

Substances

  • Central Nervous System Stimulants
  • Dopamine Agents
  • Pemoline
  • Amantadine